|
Name |
2,4,5,7-Tetrahydroxy-9-methoxy-2-methyl-1,2,3,4-tetrahydronaphthacene-6,11-dione
|
Molecular Formula | C20H18O7 | |
IUPAC Name* |
4,6,7,9-tetrahydroxy-2-methoxy-9-methyl-8,10-dihydro-7H-tetracene-5,12-dione
|
|
SMILES |
CC1(CC(C2=C(C3=C(C=C2C1)C(=O)C4=C(C3=O)C(=CC(=C4)OC)O)O)O)O
|
|
InChI |
InChI=1S/C20H18O7/c1-20(26)6-8-3-10-16(18(24)14(8)13(22)7-20)19(25)15-11(17(10)23)4-9(27-2)5-12(15)21/h3-5,13,21-22,24,26H,6-7H2,1-2H3
|
|
InChIKey |
PFPVOQDOTFXBGN-UHFFFAOYSA-N
|
|
Synonyms |
SCHEMBL17354694; 8-demethoxy-10-deoxysteffimycinone; 2,4,5,7-Tetrahydroxy-9-methoxy-2-methyl-1,2,3,4-tetrahydronaphthacene-6,11-dione
|
|
CAS | NA | |
PubChem CID | 102111462 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 370.4 | ALogp: | 1.8 |
HBD: | 4 | HBA: | 7 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 124.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 27 | QED Weighted: | 0.517 |
Caco-2 Permeability: | -5.52 | MDCK Permeability: | 0.00000706 |
Pgp-inhibitor: | 0.022 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.865 | 20% Bioavailability (F20%): | 0.051 |
30% Bioavailability (F30%): | 0.982 |
Blood-Brain-Barrier Penetration (BBB): | 0.003 | Plasma Protein Binding (PPB): | 94.32% |
Volume Distribution (VD): | 0.835 | Fu: | 11.97% |
CYP1A2-inhibitor: | 0.824 | CYP1A2-substrate: | 0.789 |
CYP2C19-inhibitor: | 0.047 | CYP2C19-substrate: | 0.061 |
CYP2C9-inhibitor: | 0.533 | CYP2C9-substrate: | 0.622 |
CYP2D6-inhibitor: | 0.16 | CYP2D6-substrate: | 0.212 |
CYP3A4-inhibitor: | 0.125 | CYP3A4-substrate: | 0.072 |
Clearance (CL): | 9.034 | Half-life (T1/2): | 0.585 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.095 |
Drug-inuced Liver Injury (DILI): | 0.937 | AMES Toxicity: | 0.55 |
Rat Oral Acute Toxicity: | 0.052 | Maximum Recommended Daily Dose: | 0.887 |
Skin Sensitization: | 0.9 | Carcinogencity: | 0.039 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.681 |
Respiratory Toxicity: | 0.283 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005543 | 0.674 | D01XWG | 0.354 | ||||
ENC000966 | 0.630 | D07VLY | 0.346 | ||||
ENC005541 | 0.627 | D0C9XJ | 0.346 | ||||
ENC005542 | 0.622 | D01XDL | 0.336 | ||||
ENC004539 | 0.606 | D0T5XN | 0.299 | ||||
ENC001063 | 0.589 | D0T8EH | 0.294 | ||||
ENC000362 | 0.566 | D07MGA | 0.288 | ||||
ENC000336 | 0.553 | D01UBX | 0.282 | ||||
ENC001497 | 0.547 | D07IPB | 0.279 | ||||
ENC005076 | 0.542 | D0N1FS | 0.270 |